Gilead outlines 2025 sales guidance with lenacapavir launch and HIV focus
Q4 2024 Management View CEO Daniel O'Day highlighted strong Q4 results with total product sales, excluding Veklury, growing 13% year-over-year to $7.2 billion. Full-year sales reached $26.8 billion, ...
Hosted on MSN46m
Leaked filing shows Musk still getting new contracts while his team cancels other contracts
Tesla and SpaceX CEO Elon Musk — by far the wealthiest person on the planet with a net worth in excess of nearly $380 billion — is now benefiting from new government contracts while simultaneously ...